How An NCI Grant Became The Impetus For Founding A Biopharma
Source: Life Science Leader
In this executive virtual roundtable (EVR) component, Prem Premsrirut, M.D., Ph.D., CEO, Mirimus, an RNAi therapeutics company, shares why she decided to take a pause in the middle of her doctoral program to found a biopharmaceutical company, along with lesson learned.
This website uses cookies to ensure you get the best experience on our website. Learn more